Thornhill D P, Field S P
Eur J Clin Pharmacol. 1982;21(4):351-4. doi: 10.1007/BF00637625.
Chronic treatment with conventional lithium carbonate was interrupted in a selected group of 40 psychiatric patients of mixed sex and race. All patients had normal renal function. Serum samples were taken 12, 24, 36 and 48 h after the last dose and lithium was assayed by atomic absorption spectrophotometry. Decay rates calculated for the 12-24h and 36-48 h periods yielded different values. This was ascribed to the presence of an incomplete redistribution phase during the earlier period. The distribution of elimination rates determined during the later period gave a more symmetrical spread and approximated a normal distribution. The mode, median, mean and standard deviation of the lithium elimination half-lives were 12.5, 14, 18.2 and 7.3h and 22.5, 24.5, 29.8 and 10.1h for the two periods, respectively. The results contrast sharply with another report of the distribution spread of elimination half-lives in a much larger sample. The current values have implications for dosage prediction, serum level monitoring and dosage formulation, especially sustained-release preparations. The evidence was against the possibility that some individuals "retain' lithium.
在一组经过挑选的40名不同性别和种族的精神病患者中,中断了常规碳酸锂的长期治疗。所有患者的肾功能均正常。在最后一剂药物后的12、24、36和48小时采集血清样本,并用原子吸收分光光度法测定锂含量。计算得出的12 - 24小时和36 - 48小时期间的衰减率值不同。这归因于早期存在不完全的再分布阶段。后期测定的消除率分布更为对称,接近正态分布。两个时期锂消除半衰期的众数、中位数、均值和标准差分别为12.5、14、18.2和7.3小时以及22.5、24.5、29.8和10.1小时。这些结果与另一篇关于更大样本中消除半衰期分布范围的报告形成鲜明对比。当前这些数值对剂量预测、血清水平监测和剂型设计,尤其是缓释制剂,具有重要意义。有证据表明一些个体“保留”锂的可能性不大。